
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.22 | -0.488888888889 | 45 | 45.77 | 43.4 | 621321 | 44.53357416 | CS |
4 | -4.85 | -9.77231513198 | 49.63 | 52.46 | 43.06 | 506093 | 46.46748879 | CS |
12 | -2.62 | -5.52742616034 | 47.4 | 52.46 | 41.5 | 500529 | 46.63417902 | CS |
26 | -4.51 | -9.14992899168 | 49.29 | 60.92 | 41.5 | 583619 | 50.2877424 | CS |
52 | 0.59 | 1.33514369767 | 44.19 | 60.92 | 36.61 | 524370 | 47.61825582 | CS |
156 | 44.49 | 15341.3793103 | 0.29 | 60.92 | 0.1302 | 735654 | 17.04894345 | CS |
260 | 42.07 | 1552.39852399 | 2.71 | 60.92 | 0.1302 | 809587 | 9.88410918 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales